NCT00911729View on ClinicalTrials.gov

Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

TerminatedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2009

Conditions
PheochromocytomaParaganglioma
Trial Locations (1)

20814

Oxford Outcomes- Nationwide Recruitment within the US, Bethesda

Sponsors
All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY

NCT00911729 - Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma | Biotech Hunter | Biotech Hunter